Ofev Interactions
There are 249 drugs known to interact with Ofev (nintedanib), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 18 are major, and 231 are moderate.
- View all 249 medications that may interact with Ofev
- View Ofev alcohol/food interactions (1)
- View Ofev disease interactions (6)
Most frequently checked interactions
View interaction reports for Ofev (nintedanib) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- atorvastatin
- benzonatate
- CellCept (mycophenolate mofetil)
- duloxetine
- Eliquis (apixaban)
- famotidine
- furosemide
- gabapentin
- Lasix (furosemide)
- levothyroxine
- lisinopril
- loperamide
- losartan
- metformin
- metoprolol
- montelukast
- multivitamin
- mycophenolate mofetil
- omeprazole
- pantoprazole
- potassium chloride
- prednisone
- rosuvastatin
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Ofev alcohol/food interactions
There is 1 alcohol/food interaction with Ofev (nintedanib).
Ofev disease interactions
There are 6 disease interactions with Ofev (nintedanib) which include:
- arterial thromboembolism
- bleeding
- gastrointestinal perforation
- hepatic impairment
- renal impairment
- smoking
Report options
QR code containing a link to this page
More about Ofev (nintedanib)
- Ofev consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (27)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
